Researchsemaglutideglp-1 receptor agonistssurgeryperioperative risk

Review weighs GLP-1 agonist use before aesthetic surgery, finds heterogeneous outcomes

Authors argue "Ozempic face" more plausibly reflects rapid weight loss than any drug-specific facial effect, and urge individualized perioperative assessment.

By Priya Raman · Science Reporter

Oct 4 20:00 ETSource: Turkish journal of surgery

The wire

01A narrative review in Turkish Journal of Surgery searched PubMed/MEDLINE from January 2015 through August 2026 on GLP-1 receptor agonist use among aesthetic surgery patients.
02Findings flag delayed wound healing, wound dehiscence, nutritional deficiency and aspiration risk in some studies, while others report comparable complication rates, relevant to perioperative planning.
03Authors say GLP-1 use is neither an advantage nor an automatic contraindication, and note evidence is heterogeneous and prospective studies are needed.

From the source

Effects of GLP-1 receptor agonists on aesthetic surgery practice: A contemporary review
Turkish journal of surgery · 2026 Oct 5 · Ersan M, Özturhan O et al.

Read at pubmed.ncbi.nlm.nih.gov

Source URL https://pubmed.ncbi.nlm.nih.gov/42830623/